Sometimes it may be the binge eating you had before your medical exam. Other times it may be the dietary recommendations that eating chicken and fish are healthier than red meat. Any animal-source food has cholesterol. According to the Center of Disease Control, 71 million Americans or 1 in 3 have high LDL or bad cholesterol levels. LDL cholesterol is associated with lining arteries with plaque that may lead to organ damage, particularly leading to heart attacks and strokes. For some people, it is dietary, and is easily controlled. For others, these may be familial, chronic conditions. There’s no wonder why cholesterol management is a big topic and essential indicator examined on general blood tests. When the American Heart Association announces new guidelines for cholesterol management, doctors listen. The new report promotes high statin dosage to control high LDL levels.
A group of researchers from the American College of Cardiology and the American Heart Association put their weight on new cholesterol management guidelines. Their emphasis is to increase statin treatments to more people who might be at risk of having a heart attack. The origin of these reports were designed to effectively care for those who already had some level of a cardiovascular episode.
As with all cases, the panel took a traditional approach. As with all patients, they emphasized lifestyle guidelines (i.e., adhering to a heart healthy diet, regular exercise
habits, avoidance of tobacco products, and maintenance of a healthy weight). They cited that use of one of the 4 statin groups would help those who can’t manage to keep their LDL at a normal range. They did not discuss HDL/LDL ratios.
Establishing a target range under real circumstances still remains vague but they deemed that an LDL-C of 190 is considered threatening.
The new guideline recommends moderate- or high-intensity statin therapy for these four groups:
1) Patients who have cardiovascular disease;
2) Patients with an LDL, or “bad” cholesterol level of 190 mg/dL or higher;
3) Patients with Type 2 diabetes who are between 40 and 75 years of age
4)Patients with an estimated 10-year risk of cardiovascular disease of 7.5 percent or higher who are between 40 and 75 years of age (the report provides formulas for calculating 10-year risk).
Chronic use of statins may have negative effects on neuromuscular systems, particularly peripheral myopathies. While Cleveland University research cites that 72.5% of statin-intolerant patients may be treated with statins. There are those that have diseases like muscular dystrophy or multiple sclerosis for which statin use may be almost fatal. Recommendations of high stain dosages may be more dangerous holistically than cardiology specialists realize.
For example, many people suffer from rheumatism and fibromyalgia. These involve muscle pains, affecting over 10 million people, that have no succinct etiology to infer causality and results. There is little data to support that high-dose statins may induce more extreme pain or inflammation. While cholesterol management is vital, average cardiologists may not take these other common diseases into consideration when prescribing statin drugs.
Specialists that read these guidelines may take easier approaches at high-dosing statins to force cholesterol management to those that may not need it. The November 2013 guidelines of the American College of Cardiologists and the American Heart Association seems to sanction this. Most cardiologists adhere to the average and this report definitely targets the average. Patients are then forced to seek out cardiologists that see patients as individuals instead of group numbers. Groupings are attractive at writing presentations. Patients as clients require more specific attention.
Yet statins are touted well beyond cholesterol management with research demonstrating efficacy in treating cancer and other diseases. It’s as if all the leading drug companies that produce cholesterol are behind all the experiments. In some respects, companies like Merck and Pfizer are using cardiologists as drug pushers, especially when two major heart organizations sanction high dosages of statin medications to help lower LDL cholesterol.
I have genetic cholesterol and management requires an almost vegan diet along with exercise. Because of a form of muscular dystrophy, all statins have been proven toxic. I use Source Natural Cholesterol Complex on a daily basis, along with non-statin prescription Zetia and Lopid. Policosanol is a key ingredient in my supplement mix and policosanol research shows that 20mg can help reduce LDL cholesterol by nearly 30%. For people that suffer from statin intolerance, statins are not the conclusive treatment.
Cholesterol is only one of many indicators that may lead to heart disease. Relying on statins to lower LDL cholesterol levels may be great for many people. For those that exhibit statin intolerance, there are other routes and physicians should understand and study these.
Sifting through this 80 page document from November, it’s a rather unimpressive work and further extends that the two leading organizations continue to fail at examining holistic approaches to cholesterol management. Cholesterol levels correlate differently with age and this report didn’t cover that well. As people rise over 70, 190 to 200 LDL is more tolerable than that of a 25 year old.
Prescribing high intensity statins as a rule instead of an exception, may actually harm some patients in those groups due to side-effects. The fervent faith in statins for cholesterol management that seems to be shared by traditional cardiologists may be taking cardiovascular care in wrong directions. There must be more exploration into alternative approaches that place responsibilities on both doctor and patient.
Finding a reasonable target that I can maintain without statins is my goal. In the overall wellness mix, I prefer to be in control. Control requires an active goal-oriented approach. That control persists between routine visits to my practitioner.
Patients, as drug consumers, will accept statins and will likely not report intolerances. While statins for lowering cholesterol may be beneficial, the overall goal is to help patients (as clients) pursue healthy lifestyles and feel well. On the patient’s side, you must be willing to take necessary drug-free steps to improve your heart and cardiovascular health. Ultimately your health is your responsibility!
As to the new stricter standards proposed by the ACC and AHA regarding cholesterol borderlines and statin medications, everything and anything is subject to change. Each year new studies and interventions lead to new perspectives of how to approach cardiovascular conditions. The ACC and AHA are traditionalists and are likely to follow Statins as a holy sword. Statins are not exclusive. Seek out other options and, if possible, find integrative health centers that offer more holistic and educational approaches to help resolve what may be a chronic condition. There are lifestyle choices that can help you manage your LDL cholesterol levels.